TG-1 * Transgallaxys Forum 1

Pages: [1]

Author Topic: cash incentives to promote prescriptions of Subsys beyond its approved parameter  (Read 18 times)

YanTing

  • Jr. Member
  • *
  • Posts: 59

cash incentives to promote prescriptions of Subsys beyond its approved parameters

"NEWARK - The State Board of Medical Examiners has revoked the license of a Warren County doctor after concluding he placed patients at risk by prescribing the tightly-restricted cancer pain medication "Subsys" to patients who did not meet the criteria for receiving it, and that he accepted more than $100,000 from the drug's maker, Insys Therapeutics Inc., to push prescriptions of the powerful opioid painkiller.

Dr. Kenneth P. Sun, a pain management practitioner in Phillipsburg, is the latest New Jersey doctor to have his license revoked for allegedly ignoring explicit prescribing restrictions placed on Subsys, a potent under-the-tongue opioid spray approved by the federal Food and Drug Administration ("FDA.") only to treat breakthrough pain in cancer patients already receiving, and tolerant to, around-the-clock opioid therapy for their underlying cancer pain. Prescribing Subsys outside its approved parameters exposes patients to grave risks, including the risk of a fatal overdose.

Sun is among numerous doctors nationwide who accepted payments from Insys - in the form of speaking and consulting fees - that were, in reality, cash incentives to promote prescriptions of Subsys beyond its approved parameters.

https://nj.gov/oag/newsreleases18/pr20180910b.html
Logged
Pages: [1]